Publicaciones 2016
  1. Youngster I, Avorn J, Belleudi V, Cantarutti A, Díez-Domingo J, Kirchmayer U, Park BJ, Peiró S, Sanfélix-Gimeno G, Schröder H, Schüssel K, Shin JY, Shin SM, Simonsen GS, Blix HS, Tong A, Trifirò G, Ziv-Baran T, Kim SC. Antibiotic Use in Children - A Cross-National Analysis of 6 Countries. J Pediatr. 2016 Dec 19. pii: S0022-3476(16)31256-2. doi: 10.1016/j.jpeds.2016.11.027 
     
  2. Krumme AA, Sanfélix-Gimeno G, Franklin JM, Isaman DL, Mahesri M, Matlin OS, Shrank WH, Brennan TA, Brill G, Choudhry NK. Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims data. BMJ Open. 2016;6(11). 
     
  3. Librero J, Ibañez-Beroiz B, Peiró S, Ridao-López M, Rodríguez-Bernal CL, Gómez-Romero FJ, Bernal-Delgado E; Spanish Atlas of Medical Practice Variation Research Group. Trends and area variations in Potentially Preventable Admissions for COPD in Spain (2002-2013): a significant decline and convergence between areas. BMC Health Serv Res. 2016;16(a):367. 
     
  4. Librero J, Sanfelix-Gimeno G, Peiro S. Medication Adherence Patterns after Hospitalization for Coronary Heart Disease. A Population-Based Study Using Electronic Records and Group-Based Trajectory Models. PLoS One. 2016;11(8):e0161381. 
     
  5. Angulo-Pueyo E, Martinez-Lizaga N, Ridao-Lopez M, Garcia-Armesto S, Bernal-Delgado E. [Trend in potentially avoidable hospitalisations for chronic conditions in Spain]. Gac Sanit. 2016;30(1):52-4. 
     
  6. Catalá-López F, Macías Saint-Gerons D, González-Bermejo D, Rosano GM, Davis BR, Ridao M, Zaragoza A, Montero-Corominas D, Tobías A, de la Fuente-Honrubia C, Tabarés-Seisdedos R, Hutton B. Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses. PLoS Med. 2016;13(3):e1001971. 
     
  7. Catala-Lopez F, Ridao M. [Reporting of conflict of interest in cost-effectiveness analyses of healthcare interventions]. Aten Primaria. 2016. 
     
  8. Catala-Lopez F, Ridao M. [Improving transparency of methods and results in cost-effectiveness analyses for cancer prevention, treatment and control]. Med Clin (Barc). 2017 Jan 6;148(1):43-45.
     
  9. Catalá-López F, Ridao M, Alonso-Arroyo A, García-Altés A, Cameron C, González-Bermejo D, Aleixandre-Benavent R, Bernal-Delgado E, Peiró S, Tabarés-Seisdedos R, Hutton B. The quality of reporting methods and results of cost-effectiveness analyses in Spain: a methodological systematic review. Syst Rev. 2016;5:6.       
     
  10. Lopez-Villegas A, Catalan-Matamoros D, Robles-Musso E, Peiro S. Workload, time and costs of the informal cares in patients with tele-monitoring of pacemakers: the PONIENTE study. Clin Res Cardiol. 2016;105(4):307-13. 
     
  11. Ridao M, Catala-Lopez F. Quality of Methods and Results Reporting in Cost-effectiveness Analyses of Cardiovascular Interventions. Rev Esp Cardiol (Engl Ed). 2016;69(9):876-7. 
     
  12. Salvador Peiró; Gabriel Sanfélix Gimeno. Datos de la Vida Real. La experiencia del área de investigación en servicios de salud de FISABIO y CSISP. En: DATOS DE LA VIDA REAL EN EL SISTEMA NACIONAL ESPAÑOL. Madrid: Fundación Gaspar Casal; 2016. pp.179 – 201